Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer

Apoptosis

Volumn 4, Issue 4, 1999, Pages 233-237

  Thompson, T C ^a   Timme, T L ^a   Li, L ^a   Goltsov, A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Androgen resistance; Caveolin 1; Metastasis; Prostate cancer

Indexed keywords

ANDROGEN; ANTINEOPLASTIC AGENT; CAVEOLIN; MESSENGER RNA;

CANCER MORTALITY; CELL SURVIVAL; HUMAN; MALIGNANT TRANSFORMATION; METASTASIS; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SHORT SURVEY;

EID: 0032831879     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009612708099     Document Type: Short Survey

References (24)

1. Thompson TC, Park SH, Timme RL, et al. Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer. Oncogene 1995; 10: 869-879.
2. Hall SJ, Thompson TC. Spontaneous metastatic activities but not experimental metastatic activities differentiate primary tumor-derived vs. metastasis-derived mouse prostate cancer cell lines. Clin Exp Metastasis 1997; 15: 484-493.
3. Yang G, Truong LD, Timme TL, et al. Elevated expression of caveolin is associated with progression in prostate and breast cancer. Clin Cancer Res 1998; 4: 1873-1880.
4. Harter T, Simons K. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr Opin Cell Biol 1997; 9: 534-542.
5. Nasu Y, Timme TL, Yang G, et al. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen insensitive mouse prostate cancer cells. Nature Med 1998; 4: 1062-1064.
6. Lavie Y, Fiucci G, Lisrovitch M. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J Biol Chem 1998; 273: 32380-32383.
7. Huang C-P, Galbati F, Volonte D, Horwitz SB, Lisanti MP. Up-regulation of caveolin-1 and caveolae in taxol-resistant A549 cells. FEBS Lett 1998; 439: 368-372.
8. Engelman JA, Wykoff CC, Yasuhara S, et al. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem 1997; 272: 16374-16381.
9. Lee SW, Reimer CL, Oh P, Campbell DB, Schnitzer JE. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 1998; 16: 1391-1397.
10. Kyprianou N, Isaacs JT. Biological significance of measurable androgen levels in the rat ventral prostate following castration. Prostate 1987; 10: 313-324.
11. Egawa S, Kadmon D, Miller GJ, Scardino PT, Thompson TC. Alterations in mRNA levels for growth-related genes after transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma. Mol Carcinog 1992; 5: 52-61.
12. Hiramatsu M, Kashimata M, Minami N, et al. Androgenic regulation of epidermal growth factor in the mouse ventral prostate. Biochem Int 1988; 17: 311-317.
13. Shabsigh A, Chang DT, Heitjan DF, et al. Rapid reduction in blood flow to the rat ventral prostate gland after castration: preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival. Prostate 1998; 36: 201-206.
14. Tenniswood MP, Montpetit ML, Leger JG, et al. Epithelial-stromal interactions and cell death in the prostate. In: Farnsworth WE, Ablin RJ, eds. The Prostate as an Endocrine Gland. Boca Raton FL: CRC Press, 1990: 187-204.
15. Coffey DS. Endocrine control of normal and abnormal growth of the prostate. In: Rajfer J. ed. Urologic Endocrinology. Philadelphia, PA, WB Saunders Co., 1986: 170-195.
16. ++-dependent endonuclease as an early event in castration-induced prostatic cell death. Prostate 1988; 13: 103-118.
17. Martikainen P, Isaacs JT. Role of calcium in the programmed death of rat prostatic glandular cells. Prostate 1990; 17: 175-188.
18. Shaul PW, Anderson RGW Role of plasmalemmal caveolae in signal transduction. Am J Physiol 1998; 275 (Lung Cell Mol Physiol 19): L843-L851.
19. Shaul PW, Anderson RGW Role of plasmalemmal caveolae in signal transduction. Am J Physiol 1998; 275 (Lung Cell Mol Physiol 19): L843-L851.
20. van Veen HW, Konings WN. Multidrug transporters from bacteria to man: similarities in structure and function. Semin Cancer Biol 1997; 8: 183-191.
21. Fielding CJ, Bist A, Fielding PE. Caveolin mRNA levels are upregulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci USA 1997; 94: 3753-3758.
22. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signalling complexes" at the plasma membrane. J Biol Chem 1998; 273: 5419-5422.
23. Vairo G, Innes KM, Adams JM. Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene 1996; 13: 1511-1519.
24. Huang DCS, O'Reilly LA, Strasser A, Cory S. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 1997; 16: 4628-4638.